Management of older (? 50 years old) HIV-infected individuals is becoming increasingly complex as many develop multiple HIV-associated-non-AIDS-defining (HANA) comorbidities at an earlier onset. We will utilize frailty measurements and neuropsychological performance (NP) tests to determine if a combination of cognitive impairment and frailty identifies vulnerable older HIV-infected individuals (n=130). In addition, we will employ innovative brain imaging techniques [including arterial spin labeling magnetic resonance imaging (ASL-MRI) and positron emission tomography using Pittsburgh B compound (PET-PiB)] to quantitatively assess perfusion and amyloid deposition in older HIV-infected individuals. We will evaluate if frailty correlates with neuroimaging biomarkers (ASL and PET-PIB) of brain integrity in older HIV-infected patients. Finally, we will determine at three year follow-up if frail older HIV-infected individuals have greater rates of change from baseline in cognitive impairment (NP testing), amyloid deposition (PET-PiB), and perfusion (ASL-MRI) compared to pre-frail or non-frail older HIV-infected individuals. This proposal will place HIV associated changes in frailty and cognition into the mainstream of national brain aging research. We will develop biomarkers that will allow for early detection of changes in brain function at the pre-frail state. It is hoped that these biomarkers will assist in the early administration of tailoed effective interventions.
Contemporary care of older ( 50 years old) HIV-infected patients has become complex and is characterized by the early onset of HIV associated non-AIDS (HANA) conditions. This proposal will: 1) increase our knowledge concerning the interaction between frailty and neuropsychological performance in older HIV-infected individuals; 2) assess the relationship between frailty and neuroimaging markers of amyloid deposition and cerebral blood. These results could assist practitioners in developing early interventions at the pre-frail state to prevent or delay subsequent transition to frailty in older IV-infected individuals.
|Thomas, Jewell B; Brier, Matthew R; Ortega, Mario et al. (2015) Weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and aging. Neurobiol Aging 36:401-12|
|Ortega, Mario; Ances, Beau M (2014) Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol 9:483-91|
|Brier, Matthew R; Thomas, Jewell B; Fagan, Anne M et al. (2014) Functional connectivity and graph theory in preclinical Alzheimer's disease. Neurobiol Aging 35:757-68|
|Wang, Liang; Day, Jonathan; Roe, Catherine M et al. (2014) The effect of APOE ?4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Alzheimer Dis Assoc Disord 28:122-7|
|Masters, Mary C; Ances, Beau M (2014) Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol 34:89-102|
|Ances, Beau M; Hammoud, Dima A (2014) Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS 9:545-51|
|Brier, Matthew R; Thomas, Jewell B; Ances, Beau M (2014) Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect 4:299-311|
|Baker, Laurie M; Paul, Robert H; Heaps, Jodi M et al. (2014) Impact of human immunodeficiency virus on neurocognition and risky behaviors in young adults. J Neurovirol 20:466-73|
|Thomas, Jewell B; Brier, Matthew R; Bateman, Randall J et al. (2014) Functional connectivity in autosomal dominant and late-onset Alzheimer disease. JAMA Neurol 71:1111-22|
|Clifford, David B; Ances, Beau M (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13:976-86|
Showing the most recent 10 out of 12 publications